DEA Moves to Classify Kratom-Related Compounds as Schedule I Controlled Substances

The US Department of Justice has moved to ban three kratom-related compounds from consumer products by classifying them as Schedule I substances, the same category as heroin and LSD. WMUR reports the DEA cited animal research showing the chemicals pose a high potential for abuse and have no accepted medical use. The compounds are currently sold as powders, chewable tablets, and liquid shots across the US.
The Health and Human Services Department has extended the public comment period until September 10 for a proposed threshold on 7-OH scheduling. KSBW notes the three compounds have been on an emergency Schedule I basis for two years. This permanent classification would effectively remove these products from store shelves nationwide.
The three semisynthetic opioid-like compounds derive from kratom, a plant native to Southeast Asia. WGAL explains these chemicals mimic opioid effects in the body. They bind to the same brain receptors as prescription painkillers. The DOJ cited research on animal effects as the primary reason for the Schedule I classification. No medical professionals currently recommend them for treatment.
The DEA first placed these compounds on an emergency Schedule I basis two years ago. WMTW reports this temporary measure allowed the government time to study the drugs and gather public input. Now the Department of Justice is moving toward a permanent ban. The emergency designation expires unless the agency takes this final step. A permanent schedule prevents companies from selling the products anywhere in America.
The Health and Human Services Department extended the comment period to September 10. KCRA states this gives Americans time to submit feedback on the 7-OH scheduling threshold. Anyone can participate in the process online. The government will review all comments before finalizing the rule. This is the last chance for consumers, businesses, and advocacy groups to voice concerns or support.
These compounds have flooded convenience stores and online retailers with minimal oversight. WBALTV notes kratom products have exploded in popularity over the past decade. Most consumers view them as herbal supplements outside FDA regulation. The permanent Schedule I classification marks a major shift in federal drug policy. It will eliminate a multimillion-dollar market and force retailers to pull these items immediately.
Publishers
6
Articles
5
Reach
6